Note 11 - Segments - Cash and Cash Equivalents and Total Assets (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Jun. 03, 2026 |
Dec. 31, 2025 |
|---|---|---|---|
| Cash and cash equivalents | $ 351 | $ 351 | $ 1,352 |
| Total assets | $ 1,685 | 1,685 | 2,677 |
| Regenerative Biotech [Member] | |||
| Cash and cash equivalents | 24 | 1,206 | |
| Total assets | 1,091 | 2,277 | |
| Consumer Health Products [Member] | |||
| Cash and cash equivalents | 327 | 146 | |
| Total assets | $ 594 | $ 400 |
| X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|